Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

203 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 101,289,495 shares of 105,337,747 outstanding shares and own 96% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (15,021,721 shares), RA CAPITAL MANAGEMENT, L.P. (8,909,091 shares), BlackRock, Inc. (6,393,567 shares), BAKER BROS. ADVISORS LP (5,840,059 shares), Novo Holdings A/S (5,549,900 shares), JANUS HENDERSON GROUP PLC (4,558,519 shares), VANGUARD GROUP INC (4,516,063 shares), Cormorant Asset Management, LP (3,406,534 shares), Frazier Life Sciences Management, L.P. (2,832,867 shares), and Paradigm Biocapital Advisors LP (2,789,172 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.